The risk of infectivity from patients with persistent infection is unknown but appears to be low and is likely to decrease over time. Because patients who recover from acute EVD and later become ill with neurological or ocular symptoms might have persistent EBOV replication, appropriate infection control practices such as those recommended for evaluating persons under investigation for EVD, should be adhered to until EBOV testing is negative. This also includes any situations where there is the possibility of contact with spinal fluid, semen, or ocular contents (., lumbar puncture, spinal anesthesia, prostate or testicular surgery and intraocular procedures). EVD survivors who have any new or recurrent ocular or neurologic symptoms should seek care for complications associated with potential EBOV persistence. EVD survivors with fever should be assessed for both common community-acquired infections (., malaria, influenza, common cold, typhoid fever, gastroenteritis, etc.) as well as possible complications related to EBOV persistence.
In his work, Dr Banerjee will call on his extensive experience from around the world including working as the WHO representative in Albania and Sudan and being seconded at the request of the UN Secretary-General to serve as UNMEER's Director of Emergency Operations for Ebola. He has also extensive experience with other national and international organizations including Médecins Sans Frontières; the UK Department for International Development in India; and the GAVI Alliance as well as working as a District Health Officer in the Ntcheu district in Malawi. His most recent role was that of Deputy Executive Director at the Partnership for Maternal, Newborn and Child Health (PMNCH). During his 20+ years in public health, he has also worked for WHO in a variety of capacities, ranging from serving as an Officer for the Immunization Programme in the WHO South-East Asia Regional Office through to leading the WHO Banda Aceh office in its response to the tsunami relief operations in 2005.